These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

952 related articles for article (PubMed ID: 27812180)

  • 1. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
    Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
    PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional significance of CD105-positive cells in papillary renal cell carcinoma.
    Matak D; Brodaczewska KK; Szczylik C; Koch I; Myszczyszyn A; Lipiec M; Lewicki S; Szymanski L; Zdanowski R; Czarnecka AM
    BMC Cancer; 2017 Jan; 17(1):21. PubMed ID: 28056882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
    Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
    Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance.
    Brodaczewska KK; Bielecka ZF; Maliszewska-Olejniczak K; Szczylik C; Porta C; Bartnik E; Czarnecka AM
    Oncol Rep; 2019 Nov; 42(5):1878-1892. PubMed ID: 31545459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo.
    Fiedorowicz M; Khan MI; Strzemecki D; Orzeł J; Wełniak-Kamińska M; Sobiborowicz A; Wieteska M; Rogulski Z; Cheda L; Wargocka-Matuszewska W; Kilian K; Szczylik C; Czarnecka AM
    Sci Rep; 2020 Mar; 10(1):5379. PubMed ID: 32214151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mesenchymal stem cell subpopulations from human amniotic membrane with dissimilar osteoblastic potential.
    Leyva-Leyva M; Barrera L; López-Camarillo C; Arriaga-Pizano L; Orozco-Hoyuela G; Carrillo-Casas EM; Calderón-Pérez J; López-Díaz A; Hernandez-Aguilar F; González-Ramírez R; Kawa S; Chimal-Monroy J; Fuentes-Mera L
    Stem Cells Dev; 2013 Apr; 22(8):1275-87. PubMed ID: 23211052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
    Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
    Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
    Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
    Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
    Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
    Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
    Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
    Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a tumor-initiating stem cell population in human renal carcinomas.
    Bussolati B; Bruno S; Grange C; Ferrando U; Camussi G
    FASEB J; 2008 Oct; 22(10):3696-705. PubMed ID: 18614581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of renal cancer stem cells from patient-derived xenografts.
    Hasmim M; Bruno S; Azzi S; Gallerne C; Michel JG; Chiabotto G; Lecoz V; Romei C; Spaggiari GM; Pezzolo A; Pistoia V; Angevin E; Gad S; Ferlicot S; Messai Y; Kieda C; Clay D; Sabatini F; Escudier B; Camussi G; Eid P; Azzarone B; Chouaib S
    Oncotarget; 2016 Mar; 7(13):15507-24. PubMed ID: 26551931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells.
    Hu J; Guan W; Liu P; Dai J; Tang K; Xiao H; Qian Y; Sharrow AC; Ye Z; Wu L; Xu H
    Stem Cell Reports; 2017 Aug; 9(2):464-477. PubMed ID: 28793246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-Dimensional Cell Culture Model Utilization in Renal Carcinoma Cancer Stem Cell Research.
    Maliszewska-Olejniczak K; Brodaczewska KK; Bielecka ZF; Czarnecka AM
    Methods Mol Biol; 2018; 1817():47-66. PubMed ID: 29959702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/ tumor initiating cell properties.
    Lichner Z; Saleh C; Subramaniam V; Seivwright A; Prud'homme GJ; Yousef GM
    Oncotarget; 2015 Mar; 6(8):5567-81. PubMed ID: 25011053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cells.
    Hsieh CH; Hsiung SC; Yeh CT; Yen CF; Chou YW; Lei WY; Pang ST; Chuang CK; Liao SK
    Oncotarget; 2017 Feb; 8(9):15593-15609. PubMed ID: 28121626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.